WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Paul Bleicher, M.D., Ph.D. will step down from his day-to-day operational responsibilities at the end of this month. Dr. Bleicher will remain a member of the Phase Forward board while applying his proven entrepreneurial talents as part of the founding team of a new venture in the next-generation healthcare informatics market.
